Literature DB >> 21466615

Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.

Lutao Du1, Xiaoyan Xiao, Chuanxin Wang, Xuhua Zhang, Ni Zheng, Lili Wang, Xin Zhang, Wei Li, Shun Wang, Zhaogang Dong.   

Abstract

Human leukocyte antigen-G (HLA-G) plays an important role in tumor cell escape. We investigated HLA-G expression and regulatory T cells (Tregs) infiltrates in patients with gastric cancer (GC), analyzed their relationship with clinicopathologic features, and characterized their role in tumor immune escape. We also investigated the plasma soluble HLA-G level and its potential in the diagnosis of GC. Effect of HLA-G on Tregs was further assessed by coculture experiments in vitro. Most interestingly, HLA-G positive expression was detected in GC tissues and it was significantly correlated with the presence of tumor-infiltrating Tregs. Patients with HLA-G positive expression or high Tregs had significantly poorer survival at 5 years after operation. Multivariate analysis indicated that HLA-G positive expression was an independent prognostic factor of GC. The coculture experiment showed overexpression of HLA-G in GC cell lines significantly enhanced the frequency of Tregs when GC cells were directly cocultured with human peripheral blood mononuclear cell. However, this effect disappeared when the indirect coculture system was applied. Some cytokines such as interleukin-6, interleukin-10, and tumor necrosis factor-α significantly changed in the coculture system. Moreover, plasma soluble HLA-G level in GC patients was higher than that in normal controls. Taken together, our results indicated that HLA-G expression was closely associated with tumor progression and involved in tumor evasion by increasing the frequency of infiltrating Tregs locally. Thus, HLA-G might be a promising predictor for disease prognosis and a possible novel target for immunotherapy in GC patients.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466615     DOI: 10.1111/j.1349-7006.2011.01951.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  30 in total

1.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

2.  Long Non-coding RNAs in Gastric Cancer: A True Relationship or miR Chance?

Authors:  Konstantinos Mavridis
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

3.  HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.

Authors:  Giuseppe Murdaca; Paola Calamaro; Francesca Lantieri; Simona Pigozzi; Luca Mastracci; Federica Grillo; Ottavia Magnani; Paola Ceppa; Francesco Puppo; Roberto Fiocca
Journal:  Virchows Arch       Date:  2018-05-29       Impact factor: 4.064

Review 4.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

5.  HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer.

Authors:  Li Zhou; Zhe-Yu Niu; Zhi-Yong Liang; Wei-Xun Zhou; Lei You; Meng-Yi Wang; Lu-Tian Yao; Quan Liao; Yu-Pei Zhao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate.

Authors:  Roberta Rizzo; Ilaria Farina; Daria Bortolotti; Elisa Galuppi; Melissa Padovan; Dario Di Luca; Marcello Govoni
Journal:  Clin Rheumatol       Date:  2016-10-24       Impact factor: 2.980

Review 7.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

8.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

9.  Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.

Authors:  Yanwen Zhang; Jianqiang Zhao; Lijun Qiu; Pei Zhang; Juan Li; Dong Yang; Xiaojuan Wei; Yali Han; Siyue Nie; Yuping Sun
Journal:  Tumour Biol       Date:  2016-03-03

10.  Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.

Authors:  Roberta Rizzo; Alessandro Trentini; Daria Bortolotti; Maria C Manfrinato; Antonella Rotola; Massimiliano Castellazzi; Loredana Melchiorri; Dario Di Luca; Franco Dallocchio; Enrico Fainardi; Tiziana Bellini
Journal:  Mol Cell Biochem       Date:  2013-06-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.